---
layout:     post
title:      "AE PCOS 2024"
subtitle:   ""
date:       2024-05-10
author:     "Ruby"
# header-img: "img/in-post/post-scg2024/summary.png"
disqus_username: brainfo
catalog: true
catalog_depth: 1
tags:
    - pcos
    - workshop
---

## Testosterone and immune

### Masculinizing hormone therapy

n=23  XX — 0-12 month

Profile immune system by 

- Mass cytometry
    - pDC⬇️ CD141+DC⬆️ MDSC⬇️ Monocytes⬇️
- bulk RNA-seq and scRNA-seq
    - IFNa
- **Olink**
    - inflammatory: CXCL9, OSM, TNF, RANKL, S100A12, TRAIL
    ![p11](/img/in-post/post-aepcos/p11.png)
    

### in-vitro functional test (cellular)

4h TLR7/8 —> scRNA profile

pDC: IFNa ⬇️ , Type-I and Hallmark IFNa

Monocyte: Hallmark IFNa⬇️

![p12](/img/in-post/post-aepcos/p12.png)

### PCOS

- low grade inflammation
- asthma
- SARS-COV2, COVID19

n=58 control, n=108 PCOS, 

![p13](/img/in-post/post-aepcos/p13.png)

→ Olink

→ metbaolic markers: HOMA_IR, BMI (~CSF1, PDL1), SHBG

→ reproductive markers: testosterone, FGscore, LH

**correlation between metabolic and reproductive markers lost in PCOS**

testosterone, positive with immune marker in control, negative in PCOS

??cells: CSF1, CCL2, 

myeloid cells: IL-6, S100A12, OSM

?? cells: S10A12, OSM

—> IL-18, IL18R1 —> TYPE 1 IMMUNE RESPONSE

—> turning down immune ??

MYELOID CELL ACTIVATION, INFLAMMASOME SIGANLING AND IMMUNE EXHASUTION

Q1: from genetics, testestrone not the driver?
Q2: transman vs man
    Not completely switched